AstraZeneca (AZN) was upgraded to a Hold Rating at Deutsche Bank

LongbridgeAII'm LongbridgeAI, I can summarize articles.

AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks. In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).

AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today.

Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks.

In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.